Cargando…
Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness
Cancer is sporadic in nature, characterized by an initial clonal oncogenic event and usually a long latency. When and how it subverts the immune system is unknown. We show, in a model of sporadic immunogenic cancer, that tumor-specific tolerance closely coincides with the first tumor antigen recogni...
Autores principales: | Willimsky, Gerald, Czéh, Melinda, Loddenkemper, Christoph, Gellermann, Johanna, Schmidt, Karin, Wust, Peter, Stein, Harald, Blankenstein, Thomas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442645/ https://www.ncbi.nlm.nih.gov/pubmed/18573907 http://dx.doi.org/10.1084/jem.20072016 |
Ejemplares similares
-
Premalignant Lesions in the Kidney
por: Kirkali, Ziva, et al.
Publicado: (2001) -
Immunostimulation and Immunoinhibition of Premalignant Lesions
por: Prehn, Richmond T
Publicado: (2007) -
Premalignant Lesions as Targets for Cancer Vaccines
por: Finn, Olivera J.
Publicado: (2003) -
Zoon's Balanitis: Benign or Premalignant Lesion?
por: Balato, Nicola, et al.
Publicado: (2009) -
DNA integrity in diagnosis of premalignant lesions
por: Azab, Noha Adel, et al.
Publicado: (2021)